Royalty Pharma plc planned insider sales
In the last twelve months insiders at Royalty Pharma plc filed 37 Form 144 notices of planned sales, 3.1 million shares worth $144.3 million at the time of filing, from 8 sellers. The latest, filed 5 October 2026: Urist Marshall (officer), 4,126 shares worth $235,595, planned for around 5 October 2026 through Merrill Lynch. One notice's value as filed does not match the share price that day; it is marked in the table.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 5 October 2026 | Urist Marshall | Officer | 4,126 | $235,595 | 5 October 2026 | 4,126 shares from 5 October 2026 | Merrill Lynch | Equity Performance Award | Form 144 |
| 28 September 2026 | Urist Marshall | Officer | 4,126 | $238,813 | 28 September 2026 | 4,126 shares from 28 September 2026 | Merrill Lynch | Equity Performance Award | Form 144 |
| 22 September 2026 | SCH Investment Partners LLC | Officer | 100,000 | $5.8 million | 22 September 2026 | None on Form 4 yet | Merrill Lynch | Acquired from issuer in private transaction | Form 144 |
| 18 August 2026 | SCH Investment Partners LLC | Officer | 100,000 | $6.0 million | 18 August 2026 | None on Form 4 yet | Merrill Lynch | Acquired from issuer in private transaction | Form 144 |
| 13 August 2026 | Terrance Coyne | Officer | 11,002 | $644,277 | 13 August 2026 | 11,002 shares from 13 August 2026 | Goldman Sachs & Co. LLC | Performance Awards | Form 144 |
| 12 August 2026 | Errol B. De Souza | Former Affiliate | 125,000 | $7.2 million | 12 August 2026 | None on Form 4 yet | J.P. Morgan Securities LLC | Conversion of LP Interests | Form 144 |
| 12 August 2026 | Errol B. De Souza | Former Affiliate | 206,352 | $11.9 million | 12 August 2026 | None on Form 4 yet | J.P. Morgan Securities LLC | Compensation; Conversion of LP Interests | Form 144 |
| 1 July 2026 | Urist Marshall | Officer | 9,099 | $508,454 | 1 July 2026 | 9,099 shares from 1 July 2026 | Merrill Lynch | Equity Performance Award | Form 144 |
| 1 July 2026 | SCH Investment Partners LLC | Officer | 100,000 | $5.7 million | 30 June 2026 | No matching Form 4 sale | Merrill Lynch | Acquired from issuer in private transaction | Form 144 |
| 24 June 2026 | Urist Marshall | Officer | 9,098 | $502,067 | 24 June 2026 | 9,098 shares from 24 June 2026 | Merrill Lynch | Equity Performance Award | Form 144 |
| 23 June 2026 | Christopher Hite | Officer | 30,000 | $1.7 million | 23 June 2026 | 380,000 shares from 23 June 2026 | Merrill Lynch | Purchase in IPO - Reserved Shares Program | Form 144 |
| 23 June 2026 | SCH Investment Partners LLC | Officer | 150,000 | $8.2 million | 23 June 2026 | No matching Form 4 sale | Merrill Lynch | Acquired from issuer in private transaction | Form 144 |
| 26 May 2026 | Terrance Coyne | Officer | 64,399 | $3.5 million | 26 May 2026 | 64,399 shares from 26 May 2026 | Goldman Sachs & Co. LLC | Performance Awards | Form 144 |
| 20 May 2026 | Urist Marshall | Officer | 13,684 | $721,837 | 20 May 2026 | 13,684 shares from 20 May 2026 | Merrill Lynch | Equity Performance Award | Form 144 |
| 14 May 2026 | Norden Gregory | Officer | 3,045 | $161,385 | 14 May 2026 | 3,045 shares from 14 May 2026 | Merrill Lynch | Vesting of restricted stock unit awards | Form 144 |
| 14 May 2026 | Urist Marshall | Officer | 13,684 | $726,138 | 14 May 2026 | 13,684 shares from 14 May 2026 | Merrill Lynch | Equity Performance Award | Form 144 |
| 28 April 2026 | Terrance Coyne | Officer | 34,791 | $1.7 million | 28 April 2026 | 34,791 shares from 28 April 2026 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 1 April 2026 | Terrance Coyne | Officer | 34,791 | $1.7 million | 1 April 2026 | 34,791 shares from 1 April 2026 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 23 March 2026 | Terrance Coyne | Officer | 34,791 | $1.6 million | 23 March 2026 | 34,791 shares from 23 March 2026 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 19 March 2026 | George Lloyd | Officer | 36,518 | $1.7 million | 19 March 2026 | No matching Form 4 sale | Goldman Sachs & Co. LLC | Acquired from issuer in private transaction | Form 144 |
| 18 March 2026 | George Lloyd | Officer | 100,462 | $4.6 million | 18 March 2026 | No matching Form 4 sale | Goldman Sachs & Co. LLC | Acquired from issuer in private transaction | Form 144 |
| 4 March 2026 | George Lloyd | Officer | 136,980 | $6.5 million | 4 March 2026 | No matching Form 4 sale | Goldman Sachs & Co. LLC | Acquired from issuer in private transaction | Form 144 |
| 2 March 2026 | Terrance Coyne | Officer | 34,791 | $1.7 million | 2 March 2026 | 34,791 shares from 2 March 2026 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 23 February 2026 | Terrance Coyne | Officer | 34,791 | $1.6 million | 23 February 2026 | 34,791 shares from 23 February 2026 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 3 February 2026 | Terrance Coyne | Officer | 135,117 | $5.8 million | 3 February 2026 | 243,541 shares from 2 February 2026 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 2 February 2026 | Terrance Coyne | Officer | 108,424 | $4.6 million | 2 February 2026 | No matching Form 4 sale | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 20 January 2026 | Terrance Coyne | Officer | 69,582 | $2.7 million | 20 January 2026 | 69,582 shares from 20 January 2026 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 7 January 2026 | George Lloyd | Officer | 495,860 | $20.5 million | 7 January 2026 | No matching Form 4 sale | Goldman Sachs & Co. LLC | Acquired from issuer in private transaction | Form 144 |
| 2 January 2026 | Terrance Coyne | Officer | 69,582 | $2.7 million | 2 January 2026 | 69,582 shares from 2 January 2026 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 16 December 2025 | Sandy Lamm LLC | Officer | 160,000 | $6.1 million | 16 December 2025 | No matching Form 4 sale | Merrill Lynch | Acquired from issuer in private transaction | Form 144 |
| 15 December 2025 | Terrance Coyne | Officer | 69,582 | $2.7 million | 15 December 2025 | 69,582 shares from 15 December 2025 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 1 December 2025 | Sandy Lamm LLC | Officer | 46,667 | $930,232 value as filed; does not match the share price that day | 1 December 2025 | No matching Form 4 sale | Merrill Lynch | Stock Bonus | Form 144 |
| 1 December 2025 | Urist Marshall | Officer | 36,484 | $1.5 million | 1 December 2025 | 243,151 shares from 1 December 2025 | Merrill Lynch | Equity Performance Award | Form 144 |
| 1 December 2025 | Terrance Coyne | Officer | 69,582 | $2.8 million | 1 December 2025 | 69,582 shares from 1 December 2025 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 24 November 2025 | Terrance Coyne | Officer | 69,582 | $2.8 million | 24 November 2025 | 69,582 shares from 24 November 2025 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 19 November 2025 | George Lloyd | Officer | 355,426 | $13.7 million | 19 November 2025 | 355,426 shares from 19 November 2025 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
| 17 November 2025 | Terrance Coyne | Officer | 69,594 | $2.7 million | 17 November 2025 | 69,594 shares from 17 November 2025 | Goldman Sachs & Co. LLC | Performance Awards; Acquired from issuer in private transaction | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.